Skip to content
Sword Bio logo
  • Services
    • Bioanalytical Services
    • Custom Biomarkers
    • MSD Assays
    • Pharmacokinetics (PK)
    • Immunogenicity
    • Modalities
      • Antibody Therapeutics
      • Cell & Gene Therapy
    • Complementary Services
      • Molecular
      • Sword High Sensitivity
  • Resources
    • Blog
    • Press
    • Video
    • Case Study
  • Our Team
  • Contact
  • Search

Month: September 2025

Advancing Biomarker Strategies in Rare Disease: Insights from Our Lunch & Learn

By Sword Bio | September 30, 2025

Last week, Sword Bio was proud to host a Lunch & Learn seminar in Cambridge, MA, where more than 20 professionals gathered to discuss one of the most pressing challenges in drug development: clinical biomarker strategy for rare diseases. We were honored to welcome Binodh DeSilva, Ph.D., Senior Vice President of Bioanalytical and Biomarker Development…

Read More...

Recent Posts

  • Five Recurring Deficiencies in Biologic Assay Submissions
  • Validating Bioanalytical Assays Under ICH M10
  • From Biologics to Gene Therapy: A Conversation with Jim McNally
  • How CRO Partnerships Accelerate Biologic Drug Development
  • Bioanalytical Challenges in Cell and Gene Therapy Products

Categories

  • Assay Development
  • Blog
  • Case Study
  • Company Update
  • Press Release

Archives

  • July 2026
  • May 2026
  • March 2026
  • February 2026
  • December 2025
  • November 2025
  • September 2025
  • July 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • April 2024
  • September 2023
  • August 2023
  • July 2023
  • May 2023
  • April 2023
Sword Bio logo
  • 866.907.9673
  • info@swordbio.com
  • Sword Bio Offices
    13295 Illinois Street, Suite 103
    Carmel, IN 46032
  • Sword Bio Labs
    2255 W. Harrison St., Suite A
    Chicago, IL 60612
  • Sitemap

Copyright © 2026 Sword Bio

Limited Use Label License